Related Experiment Videos
[Thrombolytic treatment of myocardial infarction. Data on the limitation of infarction size and left ventricular
P Barraud1, X Marcaggi, M Boueyre
1Service de cardiologie & maladies vasculaires, CHU Saint-Jacques, Clermont-Ferrand.
Insights
Thrombolysis effectively restores blood flow in myocardial infarction, reducing mortality by limiting infarct size and preserving ventricular function when administered early. This treatment improves outcomes compared to conventional therapies.
Area of Science:
- Cardiovascular Therapeutics
- Interventional Cardiology
Background:
- Thrombolysis is a key treatment for acute myocardial infarction (MI).
- Early administration of thrombolysis significantly reduces mortality in MI patients.
- Reduced mortality is linked to infarct size limitation and preserved ventricular function.
Purpose of the Study:
- To review the efficacy of thrombolysis in cardiovascular therapeutics.
- To analyze factors influencing infarct size and left ventricular function post-MI.
- To compare thrombolysis with conventional therapy regarding infarct size and ventricular function.
Main Methods:
- Review of large-scale clinical trials and literature on thrombolysis.
- Assessment of infarct size using methods like Thallium 201 scintigraphy.
- Evaluation of left ventricular function via angiography and angioscintigraphy.
Main Results:
- Thrombolysis significantly reduces mortality when given early after MI symptom onset.
- Factors like collateral circulation and reocclusion also influence final infarct size.
- Thrombolysis is associated with smaller infarct size and better ventricular function compared to conventional therapy.
Conclusions:
- Thrombolysis is an effective reperfusion strategy in acute myocardial infarction.
- Early intervention with thrombolysis improves patient survival and cardiac function.
- Thrombolytic agents preserve left ventricular function and reduce infarct size.
Abstract:
Since its introduction in cardiovascular therapeutics, thrombolysis has established itself as an effective procedure of coronary reperfusion during the acute phase of myocardial infarction. Large scale clinical trials have demonstrated a clear cut reduction in mortality providing that the treatment is administered sufficiently early after the onset of symptoms. This reduced mortality is probably related to the limitation of infarct size and the conservation of ventricular function even though this relationship is not always analysed. Studies of infarct size and left ventricular function are difficult to perform and this is reflected in the number of different methods proposed. Apart from coronary reperfusion and its timing, other factors influence the definite size of the infarct, such as the development of a collateral circulation, the existence of cellular reperfusion lesions and the occurrence of reocclusion. The infarct size may be assessed by a number of methods, some simple (enzymes, electrocardiogram) but relatively inaccurate, others more promising but difficult to perform and more costly. Thallium 201 scintigraphy seems to be the best available method and our experience is based on these results. The reference method for the evaluation of left ventricular function is angiography but angioscintigraphy also provides information on global and regional function, the regional study being particularly valuable in the analysis of thrombolytic drug efficacy. A review of the literature shows that thrombolysis is associated with a reduction in infarct size compared with conventional therapy and with conservation of left ventricular function whichever thrombolytic agent is used.(ABSTRACT TRUNCATED AT 250 WORDS)